| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.33B | 98.26B | 124.86B | 123.90B | 119.32B | 120.00B |
| Gross Profit | 22.91B | 22.66B | 25.31B | 24.18B | 22.51B | 21.47B |
| EBITDA | 8.55B | 8.29B | 10.13B | 7.91B | 7.18B | 5.82B |
| Net Income | 5.04B | 4.76B | 5.48B | 3.52B | 2.80B | 2.35B |
Balance Sheet | ||||||
| Total Assets | 75.55B | 81.07B | 81.07B | 83.21B | 79.23B | 76.20B |
| Cash, Cash Equivalents and Short-Term Investments | 41.30B | 38.71B | 38.70B | 20.88B | 19.16B | 15.94B |
| Total Debt | 9.42B | 9.55B | 10.19B | 10.99B | 12.51B | 12.85B |
| Total Liabilities | 31.57B | 36.44B | 40.20B | 47.82B | 46.02B | 45.02B |
| Stockholders Equity | 43.57B | 44.16B | 40.40B | 34.95B | 32.85B | 30.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.13B | 4.01B | 3.17B | 3.69B | -1.44B |
| Operating Cash Flow | 0.00 | 3.41B | 4.95B | 4.26B | 5.56B | 749.00M |
| Investing Cash Flow | 0.00 | -792.00M | 15.47B | 39.00M | -4.00M | -1.27B |
| Financing Cash Flow | 0.00 | -2.60B | -2.61B | -2.61B | -2.41B | -2.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥45.09B | 16.86 | ― | 3.48% | 18.42% | 51.06% | |
78 Outperform | ¥48.70B | 7.95 | ― | 1.90% | 12.47% | 21.98% | |
77 Outperform | ¥63.79B | 11.67 | 16.91% | 2.28% | 12.37% | 26.48% | |
75 Outperform | ¥60.66B | 10.50 | ― | 2.82% | -5.63% | 52.73% | |
74 Outperform | ¥66.59B | 9.41 | ― | 1.52% | 5.75% | 59.69% | |
74 Outperform | ¥25.80B | 3.83 | ― | 3.66% | -18.88% | 42.17% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |